{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-03-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "country": "United States",
      "city": "Athens",
      "address_1": "340 W State St Unit 9",
      "reason_for_recall": "Lack of Assurance of Sterility; autoclave parameters were not correct for one of two autoclaves used to sterilize the product.",
      "address_2": "",
      "product_quantity": "945 vials",
      "code_info": "Lot: 04252017@1, exp 5/9/2018",
      "center_classification_date": "20171018",
      "distribution_pattern": "TX, LA, PA, MA, FL, and OH",
      "state": "OH",
      "product_description": "methylPREDNIsolone ACETATE, 40 MG/ML INJECTION SUSPENSION, 10 ML Vial, RXQ Compounding, Athens, OH --- NDC:  70731-0936-10",
      "report_date": "20171025",
      "classification": "Class II",
      "openfda": {},
      "recalling_firm": "RXQ Compounding LLC",
      "recall_number": "D-0012-2018",
      "initial_firm_notification": "Telephone",
      "product_type": "Drugs",
      "event_id": "78175",
      "termination_date": "20171206",
      "more_code_info": "",
      "recall_initiation_date": "20170925",
      "postal_code": "45701-1564",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "status": "Terminated"
    }
  ]
}